AU567780B2 - Chlorocefadroxil monohydrate - Google Patents

Chlorocefadroxil monohydrate

Info

Publication number
AU567780B2
AU567780B2 AU36321/84A AU3632184A AU567780B2 AU 567780 B2 AU567780 B2 AU 567780B2 AU 36321/84 A AU36321/84 A AU 36321/84A AU 3632184 A AU3632184 A AU 3632184A AU 567780 B2 AU567780 B2 AU 567780B2
Authority
AU
Australia
Prior art keywords
chlorocefadroxil
monohydrate
chlorocefadroxil monohydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU36321/84A
Other languages
English (en)
Other versions
AU3632184A (en
Inventor
Daniel Bouzard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of AU3632184A publication Critical patent/AU3632184A/en
Application granted granted Critical
Publication of AU567780B2 publication Critical patent/AU567780B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU36321/84A 1983-12-06 1984-12-05 Chlorocefadroxil monohydrate Ceased AU567780B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8319463 1983-12-06
FR8319463A FR2555989B1 (fr) 1983-12-06 1983-12-06 Monohydrate de chlorocephadroxyle

Publications (2)

Publication Number Publication Date
AU3632184A AU3632184A (en) 1985-06-13
AU567780B2 true AU567780B2 (en) 1987-12-03

Family

ID=9294877

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36321/84A Ceased AU567780B2 (en) 1983-12-06 1984-12-05 Chlorocefadroxil monohydrate

Country Status (25)

Country Link
JP (1) JPH0794461B2 (fr)
KR (1) KR920001769B1 (fr)
AT (1) AT386411B (fr)
AU (1) AU567780B2 (fr)
BE (1) BE901218A (fr)
CA (1) CA1246545A (fr)
CH (1) CH662569A5 (fr)
CY (1) CY1559A (fr)
DE (1) DE3444367A1 (fr)
DK (1) DK579984A (fr)
ES (1) ES8605279A1 (fr)
FI (1) FI81104C (fr)
FR (1) FR2555989B1 (fr)
GB (1) GB2150931B (fr)
GR (1) GR81159B (fr)
HK (1) HK72590A (fr)
IE (1) IE57832B1 (fr)
IT (1) IT1177370B (fr)
LU (1) LU85670A1 (fr)
MY (1) MY102192A (fr)
NL (1) NL8403670A (fr)
SE (1) SE8406171L (fr)
SG (1) SG48890G (fr)
YU (1) YU45221B (fr)
ZA (1) ZA849415B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2505697A1 (fr) * 1981-05-12 1982-11-19 Humblot Bernard Unite perfectionnee de soudage electrique

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3489751A (en) * 1967-09-05 1970-01-13 Bristol Myers Co 7-amino-cephalosporanic and decephalosporanic acid derivatives
US4160863A (en) * 1977-04-07 1979-07-10 Bristol-Myers Company Process for the preparation of the crystalline monohydrate of 7-[D-α-aα-(p-hydroxyphenyl)acetamido]-3-methyl-3-cephem-4-carboxylic acid
AU3589784A (en) * 1983-12-01 1985-06-06 Eli Lilly And Company Improvements in or relating to cephalosporin derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US516047A (en) * 1894-03-06 Wire bed-bottom
US3781282A (en) * 1971-01-20 1973-12-25 W Garbrecht Cephalosporin process and product
YU39709B (en) * 1972-09-15 1985-04-30 Bristol Myers Co Process for producing cephalosporin
US3985741A (en) * 1972-09-15 1976-10-12 Bristol-Myers Company Production of p-hydroxycephalexin
DE2317179C2 (de) * 1973-04-05 1982-11-25 Bristol-Myers Co., 10154 New York, N.Y. Verfahren zur Herstellung der relativ wasserunlöslichen kristallinen Form von Cefalexinmonohydrat
GB1532682A (en) * 1976-04-27 1978-11-22 Bristol Myers Co Process for the preparation of cephadroxil
JPS5356311A (en) * 1976-10-28 1978-05-22 Toyama Chem Co Ltd Cefalexin monohydrate having novel crystal form and process for preparationof the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3489751A (en) * 1967-09-05 1970-01-13 Bristol Myers Co 7-amino-cephalosporanic and decephalosporanic acid derivatives
US4160863A (en) * 1977-04-07 1979-07-10 Bristol-Myers Company Process for the preparation of the crystalline monohydrate of 7-[D-α-aα-(p-hydroxyphenyl)acetamido]-3-methyl-3-cephem-4-carboxylic acid
AU3589784A (en) * 1983-12-01 1985-06-06 Eli Lilly And Company Improvements in or relating to cephalosporin derivatives

Also Published As

Publication number Publication date
YU207384A (en) 1987-12-31
GB2150931A (en) 1985-07-10
CA1246545A (fr) 1988-12-13
YU45221B (en) 1992-05-28
DK579984A (da) 1985-06-07
ES538235A0 (es) 1986-03-16
FI81104C (fi) 1990-09-10
GB2150931B (en) 1987-07-29
DE3444367A1 (de) 1985-06-20
IE57832B1 (en) 1993-04-21
CY1559A (en) 1991-03-22
GR81159B (en) 1985-04-08
IT8423909A1 (it) 1986-06-05
JPH0794461B2 (ja) 1995-10-11
FR2555989A1 (fr) 1985-06-07
ATA386384A (de) 1988-01-15
SE8406171L (sv) 1985-06-07
FI844756A0 (fi) 1984-12-03
FR2555989B1 (fr) 1987-02-20
JPS60139695A (ja) 1985-07-24
FI844756L (fi) 1985-06-07
DE3444367C2 (fr) 1993-04-29
ES8605279A1 (es) 1986-03-16
FI81104B (fi) 1990-05-31
AT386411B (de) 1988-08-25
LU85670A1 (fr) 1985-09-12
AU3632184A (en) 1985-06-13
SG48890G (en) 1990-08-17
BE901218A (fr) 1985-06-05
CH662569A5 (fr) 1987-10-15
SE8406171D0 (sv) 1984-12-05
NL8403670A (nl) 1985-07-01
IE843117L (en) 1985-06-06
IT8423909A0 (it) 1984-12-05
IT1177370B (it) 1987-08-26
KR850004494A (ko) 1985-07-15
HK72590A (en) 1990-09-21
DK579984D0 (da) 1984-12-05
KR920001769B1 (ko) 1992-03-02
ZA849415B (en) 1985-07-31
MY102192A (en) 1992-04-30
GB8430753D0 (en) 1985-01-16

Similar Documents

Publication Publication Date Title
AU2773884A (en) Pyridyl- and pyrimidyl- sulphonamides
AU2810384A (en) Nivamaler
AU2836184A (en) Desensitiser
AU2670684A (en) N-aryl-alpha-amino-carboxamides
AU2768784A (en) Carry-cot
AU2867284A (en) Korpertrainingsgerat
AU2478684A (en) Branch-copolymers
AU2809484A (en) N-pyridylindoles
AU2449484A (en) N-piperazinylalkanoylanilides
AU2692984A (en) Benzoquinolizines
AU2743684A (en) 4-phenyl-tetrahydro-furano-pyridines
AU2543484A (en) Sky-light
AU2445584A (en) D-homosteroids
AU2454184A (en) Aroylimidazolones
AU2610884A (en) Benzobisoxazinetetra-ones
AU2580684A (en) Pyridyl-benzoxazines
AU2814784A (en) Larmsystem
AU2682284A (en) Diphenylazomethines
AU567780B2 (en) Chlorocefadroxil monohydrate
AU2745984A (en) N-cyclohexadienyl-chloroacetamides
AU2610084A (en) 4-substituted-2-azetidinones
AU2377084A (en) 1-substituted - triazolobenzodiazepines
AU2817084A (en) Skumudlaegningsapparat
AU2694984A (en) Acidifier-ammoniator
AU2820584A (en) Hydraulisk drevet pumpeaggregat